Milestone Pharmaceuticals (MIST) Other Accumulated Expenses (2018 - 2026)

Milestone Pharmaceuticals (MIST) has 9 years of Other Accumulated Expenses data on file, last reported at $43000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 88.65% year-over-year to $43000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 88.65% YoY) and the FY2025 annual result came in at $43000.0, down 91.04% from the prior year.
• Other Accumulated Expenses held at $43000.0 in Q1 2026, from $43000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.3 million in Q3 2023 to a low of $43000.0 in Q4 2025.
• A 5-year average of $472941.2 and a median of $392000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 212.93% — and 2025, when it sank 91.04%.
• Tracing MIST's Other Accumulated Expenses over 5 years: stood at $255000.0 in 2022, then retreated by 1.18% to $252000.0 in 2023, then jumped by 90.48% to $480000.0 in 2024, then slumped by 91.04% to $43000.0 in 2025, then changed by 0.0% to $43000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $43000.0 (Q1 2026), $43000.0 (Q4 2025), and $518000.0 (Q3 2025), per Business Quant data.